Trial intelligence / Profile preview

Special Drug Use Surveillance of Azilva (azilsartan) in Pediatric Hypertension

jRCT2031210414Completed

Sponsor
Takeda
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of azilsartan in hypertension (HTN), sponsored by Takeda. Started Dec 2021; status: completed.

02

Drugs

azilsartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on jRCT2031210414.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2031210414.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call